Longevity Insights — Page 2
Evidence-based perspectives on longevity medicine, healthspan, and the everyday systems that shape how well you live. Short enough to use, serious enough to trust, and always connected to a physician-led view.
The Maximum Letter · Newsletter
Sign up for The Maximum Letter.
Medical perspective, research signals, and practical guidance for people who want more good years — without the wellness noise.
Filter Articles
Senolytics Are Moving From Proof of Concept to Early Human Signals
Senolytics target senescent cells, a biologically active cell state linked to inflammation, tissue dysfunction, and aging-related disease. The promise is real—but so are the risks, unknowns, and need for physician-led precision.
GLP-1s, Peptides, and Longevity: What’s Real Beyond the Hype
GLP-1 medications have changed metabolic medicine because they are supported by clinically meaningful human outcomes, not because they are “longevity hacks.” Here’s how to think clearly about peptide therapeutics, evidence tiers, muscle preservation, monitoring, and physician-led personalization.
Rapamycin and mTOR, Explained Simply
Rapamycin is one of the most studied molecules in aging biology, but the human evidence is still specific and cautious. Here is what mTOR does, why the science matters, and why any use should be personalized and medically supervised.
Polyphenols, Sea Vegetables, and Food as Biological Signal
Polyphenols and sea vegetables are useful not because they are superfoods, but because food carries signals that influence metabolism, inflammation, vascular health, and the gut.
Partial Cellular Reprogramming: Frontier Science, Not Protocol
Partial cellular reprogramming may eventually change how medicine thinks about aging. For now, it is powerful frontier science — not an available consumer protocol.
Protein, Muscle, and Aging After 65
After 65, maintaining muscle becomes less automatic and more intentional. This guide explains anabolic resistance, sarcopenia, protein distribution, resistance training, and the kidney caveats that matter when considering higher protein intake.
Stress Is a Biological Signal — Here’s How to Listen
Chronic stress changes breathing, sleep, blood sugar, inflammation, digestion, and repair. The goal is not to eliminate stress, but to build a nervous system that can respond, recover, and return to balance.
The Foundation-First Longevity Pyramid
Longevity does not start with the newest therapy. It starts with the daily signals that shape metabolism, inflammation, sleep, muscle, stress resilience, and connection — then uses data and clinical support to personalize what comes next.
Senolytics and “Zombie Cells”
Senolytics may one day help target age-related disease by clearing some senescent cells. Here is what the evidence shows, what it does not show, and why clinical discipline matters.
Before You Supplement, Understand What You Need
Supplements are often treated as shortcuts to better health. Without context, they can become expensive guesswork. A TML approach starts with understanding your biology before designing a plan.
Understanding the 12 Hallmarks of Aging: A Roadmap for Longevity
In January 2023, scientists expanded the "Hallmarks of Aging" from nine to twelve, providing the most comprehensive map yet of the biological processes that drive human aging. Understanding these hallmarks is the foundation for making informed decisions about your longevity strategy.
What Biological Age Can—and Can’t—Tell You
Biological age testing can help reveal patterns and track change over time. But it is not a verdict, a diagnosis, or a number to chase in isolation.
Showing 13-24 of 29 articles